Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

CP Kelco UK Ltd
Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400
Contact CP Kelco UK Ltd
Website

 Latest Content from PMHub 

Creating content to trigger behaviour change

White Papers and Resources | July 14, 2022 | Havas Life London

As part of the development of content and communication strategies in healthcare, we mine for insights into audience behaviours – identifying what HCPs or patients think and how they act;...

Device Technology and Innovations

Press Releases | July 14, 2022 | Medscape Education

The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...

Infographic: Therapy Watch Lupus

White Papers and Resources | July 14, 2022 | Inizio

Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.

Article: Getting their lives back: Improving options for people with Lupus

White Papers and Resources | July 14, 2022 | Inizio

Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Press Releases | July 14, 2022 | Wilmington Healthcare

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

Accelerating patient recruitment post-COVID-19

White Papers and Resources | July 12, 2022 | Innovative Trials

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Genesis Research Acquires Market Access Transformation

Press Releases | July 11, 2022 | Genesis Research Group

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

Press Releases | July 11, 2022 | Bedrock Healthcare Communications

The award recognises outstanding achievement in flexing thinking and processes to ensure success.

ISPOR 2022: a retrospective

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research – an introduction

Videos and Podcasts | July 11, 2022 | Genesis Research Group